High GLI-1 Expression is a Reliable Indicator of Bad Prognosis in Newly Diagnosed Acute Leukemia Patients
Conclusion: GLI-1 overexpression is a risk factor for poor prognosis and could be a novel therapeutic target for AML.
Source: Indian Journal of Hematology and Blood Transfusion - Category: Hematology Source Type: research
More News: Acute Leukemia | Acute Myeloid Leukemia | Blood Transusion | Chemotherapy | Genetics | Hematology | India Health | Leukemia